187,486 Shares in Healthpeak Properties, Inc. (NYSE:DOC) Bought by Twinbeech Capital LP

Twinbeech Capital LP bought a new position in Healthpeak Properties, Inc. (NYSE:DOC) during the 4th quarter, HoldingsChannel reports. The fund bought 187,486 shares of the real estate investment trust’s stock, valued at approximately $3,800,000.

Other hedge funds also recently made changes to their positions in the company. Mizuho Bank Ltd. purchased a new position in shares of Healthpeak Properties in the fourth quarter worth $28,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Healthpeak Properties in the fourth quarter worth $30,000. Covestor Ltd increased its stake in shares of Healthpeak Properties by 173.8% in the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock worth $37,000 after buying an additional 1,152 shares during the period. Kestra Investment Management LLC purchased a new position in shares of Healthpeak Properties in the fourth quarter worth $45,000. Finally, Kapitalo Investimentos Ltda purchased a new position in shares of Healthpeak Properties in the fourth quarter worth $46,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $17.49 on Wednesday. Healthpeak Properties, Inc. has a 12 month low of $16.90 and a 12 month high of $23.26. The stock has a market cap of $12.15 billion, a PE ratio of 49.97, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The company’s fifty day moving average price is $18.68 and its 200-day moving average price is $19.99.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm had revenue of $702.89 million for the quarter, compared to analysts’ expectations of $690.76 million. During the same quarter in the previous year, the business posted $0.45 EPS. The company’s quarterly revenue was up 15.9% on a year-over-year basis. On average, equities analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be issued a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date is Monday, May 19th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 305.00%.

Analysts Set New Price Targets

DOC has been the topic of several analyst reports. Wedbush decreased their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Monday, April 28th. Scotiabank decreased their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a “sector outperform” rating on the stock in a research note on Monday, May 12th. Robert W. Baird cut their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a report on Tuesday, April 29th. Argus reiterated a “buy” rating and issued a $25.00 price target on shares of Healthpeak Properties in a report on Tuesday, April 29th. Finally, Evercore ISI cut their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $23.45.

Insider Activity

In other Healthpeak Properties news, Director John T. Thomas bought 4,200 shares of the company’s stock in a transaction dated Monday, April 28th. The shares were purchased at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the acquisition, the director now owns 813,566 shares in the company, valued at approximately $14,514,017.44. This represents a 0.52% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Scott M. Brinker bought 2,750 shares of the company’s stock in a transaction dated Friday, May 9th. The shares were acquired at an average price of $17.39 per share, for a total transaction of $47,822.50. Following the acquisition, the chief executive officer now owns 204,613 shares in the company, valued at approximately $3,558,220.07. This represents a 1.36% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 23,987 shares of company stock worth $422,141. Corporate insiders own 0.23% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.